← SearchDEVELOPMENT OF NOVEL RHO KINASE INHIBITORS FOR TREATMENT OF PULMONARY HYPERTENSION$519,575FY2014Department of DefenseDODAnacor Pharmaceuticals, Inc., Palo Alto CAInvestigatorsView source on USAspending →